Brooks Laboratories Limited (NSE:BROOKS)
India
· Delayed Price · Currency is INR 147.19
+6.54 (4.65%)
Apr 24, 2025, 3:29 PM IST
Brooks Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 769.62 | 794.86 | 632.05 | 911.85 | 772.47 | 696.89 | Upgrade
|
| Revenue Growth (YoY) | 3.36% | 25.76% | -30.69% | 18.04% | 10.85% | 26.64% | Upgrade
|
| Cost of Revenue | 513.35 | 569.73 | 524.09 | 639.79 | 485.69 | 471.42 | Upgrade
|
| Gross Profit | 256.26 | 225.13 | 107.95 | 272.06 | 286.78 | 225.46 | Upgrade
|
| Selling, General & Admin | 121.08 | 107.94 | 176.94 | 194.68 | 146.43 | 140.43 | Upgrade
|
| Other Operating Expenses | 90.89 | 78.51 | 194.77 | 217.67 | 134.57 | 108.19 | Upgrade
|
| Operating Expenses | 228.68 | 204.19 | 441.97 | 485.86 | 352.44 | 315.1 | Upgrade
|
| Operating Income | 27.59 | 20.94 | -334.02 | -213.8 | -65.66 | -89.64 | Upgrade
|
| Interest Expense | -9.21 | -7.25 | -19.54 | -28.31 | -30.98 | -32.72 | Upgrade
|
| Interest & Investment Income | 1.07 | 1.07 | 1.27 | 0.91 | 1.85 | 1.55 | Upgrade
|
| Earnings From Equity Investments | -200.98 | -211.21 | -33.1 | - | -0.08 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 1.53 | 1.53 | -0.43 | 2.22 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -1.6 | -1.2 | -1.53 | -1.31 | 5.51 | -0.79 | Upgrade
|
| EBT Excluding Unusual Items | -181.6 | -196.11 | -387.35 | -240.29 | -89.37 | -121.6 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.08 | 0.08 | 0.08 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 1.31 | -0.56 | -13.54 | Upgrade
|
| Other Unusual Items | 0.37 | 0.37 | 3.57 | - | - | - | Upgrade
|
| Pretax Income | -181.15 | -195.66 | -383.7 | -238.98 | -89.93 | -135.14 | Upgrade
|
| Income Tax Expense | - | 0.26 | -73.24 | -45.85 | 103.82 | 108.62 | Upgrade
|
| Earnings From Continuing Operations | -181.15 | -195.92 | -310.46 | -193.13 | -193.76 | -243.76 | Upgrade
|
| Minority Interest in Earnings | - | - | 101.54 | 80.23 | - | - | Upgrade
|
| Net Income | -181.15 | -195.92 | -208.92 | -112.9 | -193.76 | -243.76 | Upgrade
|
| Net Income to Common | -181.15 | -195.92 | -208.92 | -112.9 | -193.76 | -243.76 | Upgrade
|
| Shares Outstanding (Basic) | 26 | 26 | 25 | 25 | 25 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 26 | 25 | 25 | 25 | 18 | Upgrade
|
| Shares Change (YoY) | 2.88% | 3.70% | - | - | 40.27% | 8.80% | Upgrade
|
| EPS (Basic) | -6.94 | -7.65 | -8.46 | -4.57 | -7.84 | -13.84 | Upgrade
|
| EPS (Diluted) | -6.94 | -7.65 | -8.46 | -4.57 | -7.84 | -13.84 | Upgrade
|
| Free Cash Flow | - | -101.2 | -149.58 | -650.53 | -11.55 | -119.72 | Upgrade
|
| Free Cash Flow Per Share | - | -3.95 | -6.05 | -26.33 | -0.47 | -6.80 | Upgrade
|
| Gross Margin | 33.30% | 28.32% | 17.08% | 29.84% | 37.13% | 32.35% | Upgrade
|
| Operating Margin | 3.58% | 2.63% | -52.85% | -23.45% | -8.50% | -12.86% | Upgrade
|
| Profit Margin | -23.54% | -24.65% | -33.05% | -12.38% | -25.08% | -34.98% | Upgrade
|
| Free Cash Flow Margin | - | -12.73% | -23.67% | -71.34% | -1.49% | -17.18% | Upgrade
|
| EBITDA | 3.61 | 35.77 | -267.44 | -143.15 | 3.15 | -25.76 | Upgrade
|
| EBITDA Margin | 0.47% | 4.50% | -42.31% | -15.70% | 0.41% | -3.70% | Upgrade
|
| D&A For EBITDA | -23.98 | 14.83 | 66.58 | 70.65 | 68.82 | 63.89 | Upgrade
|
| EBIT | 27.59 | 20.94 | -334.02 | -213.8 | -65.66 | -89.64 | Upgrade
|
| EBIT Margin | 3.58% | 2.63% | -52.85% | -23.45% | -8.50% | -12.86% | Upgrade
|
| Revenue as Reported | 778.78 | 804.42 | 634.16 | 919.86 | 779.82 | 700.95 | Upgrade
|
| Advertising Expenses | - | 2.45 | 3.43 | 2.6 | 2.57 | 6.47 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.